OncoSec Medical Incorporated (ONCS): Price and Financial Metrics
ONCS Price/Volume Stats
Current price | $0.28 | 52-week high | $20.46 |
Prev. close | $0.21 | 52-week low | $0.18 |
Day low | $0.25 | Volume | 52,491,000 |
Day high | $0.40 | Avg. volume | 2,219,449 |
50-day MA | $0.63 | Dividend yield | N/A |
200-day MA | $3.69 | Market Cap | 1.26M |
ONCS Stock Price Chart Interactive Chart >
OncoSec Medical Incorporated (ONCS) Company Bio
OncoSec Medical Inc. provides biomedical services. The Company focuses on commercializing therapeutic oncology products. OncoSec Medical offers patients with alternative treatments to existing therapies to treat cancerous tumors and cancerous cells.
Latest ONCS News From Around the Web
Below are the latest news stories about ONCOSEC MEDICAL INC that investors may wish to consider to help them evaluate ONCS as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start breaking down the biggest pre-market movers for Thursday as we get ready for another busy day of trading! |
Why Are Chinese Stocks BABA, JD, PDD Up Today?Chinese stocks are on the rise Thursday as investors react to Alibaba (BABA) expansion plans and lowered interest rates. |
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?OncoSec Medical (ONCS) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy. |
XPEV Stock Alert: Xpeng Expands Assisted Driving TechXpeng (XPEV) stock is on the move Thursday after the Chinese EV company expanded its assisted driving technology to Beijing. |
OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesOncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shares of its common stock, at a purchase price of $0.945 per share, priced at-the-market under Nasdaq rules. The Company also issued in a concurrent private placem |
ONCS Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | -87.44% |
3-year | -99.74% |
5-year | -99.77% |
YTD | N/A |
2023 | 0.00% |
2022 | -92.04% |
2021 | -85.12% |
2020 | 256.35% |
2019 | -71.72% |
Loading social stream, please wait...